scholarly article | Q13442814 |
P50 | author | Jiejie Xu | Q87993892 |
P2093 | author name string | Hao Liu | |
He Li | |||
Heng Zhang | |||
Jing Qin | |||
Zhenbin Shen | |||
Hongyong He | |||
Yifan Cao | |||
Songyang Wu | |||
Rochen Li | |||
P2860 | cites work | Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells | Q24321607 |
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy | Q27002646 | ||
CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. | Q48099359 | ||
Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer. | Q48626617 | ||
C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy. | Q50650527 | ||
Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. | Q51049738 | ||
Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. | Q54674032 | ||
Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer | Q70511127 | ||
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma | Q81351659 | ||
Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppression | Q83735256 | ||
Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-β1 | Q84418006 | ||
Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection | Q85330142 | ||
Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer | Q85722982 | ||
GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma | Q87759994 | ||
Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution | Q87885346 | ||
OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs | Q110949771 | ||
Innate and adaptive immune cells in the tumor microenvironment | Q27008342 | ||
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer | Q27853326 | ||
Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo | Q28203975 | ||
Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
The future of immune checkpoint therapy | Q28259862 | ||
Fc receptor gamma-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responses | Q28302398 | ||
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications | Q31059425 | ||
Family history and the risk of gastric cancer | Q33630778 | ||
Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia | Q33688225 | ||
American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group | Q33875909 | ||
Macrophage-derived chemokine (MDC). | Q34031541 | ||
The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse | Q34171959 | ||
The role of the CCL22-CCR4 axis in the metastasis of gastric cancer cells into omental milky spots | Q34256831 | ||
Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity | Q34495723 | ||
Increase of regulatory T cells in the peripheral blood of cancer patients. | Q34531138 | ||
Chemotherapy for advanced gastric cancer: across the years for a standard of care | Q34617795 | ||
Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time | Q35772513 | ||
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. | Q35912196 | ||
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma | Q36288217 | ||
Neo-adjuvant and adjuvant chemotherapy of gastric cancer | Q36860125 | ||
Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. | Q37346143 | ||
High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment | Q37650692 | ||
Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer | Q37711697 | ||
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. | Q38667837 | ||
Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression. | Q38830643 | ||
Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity | Q39156200 | ||
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial | Q40046733 | ||
Human ovarian carcinoma cells generate CD4(+)CD25(+) regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-beta | Q40160226 | ||
Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer | Q40365739 | ||
Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma | Q41792382 | ||
Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes | Q43588267 | ||
Overproduction of IgE induces macrophage-derived chemokine (CCL22) secretion from basophils | Q46333876 | ||
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. | Q46373510 | ||
Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer. | Q47131106 | ||
Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery | Q47652727 | ||
Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum. | Q47975537 | ||
ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis | Q48026306 | ||
P433 | issue | 6 | |
P921 | main subject | chemotherapy | Q974135 |
P304 | page(s) | e1433517 | |
P577 | publication date | 2018-03-06 | |
P1433 | published in | OncoImmunology | Q18026500 |
P1476 | title | C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer | |
P478 | volume | 7 |
Q89724967 | CCL22 Signaling in the Tumor Environment |
Q92593617 | Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment |
Q92013108 | Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients |
Q64103418 | M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling |
Q90106921 | Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer |
Search more.